Wave Life Sciences Gains Shareholder Approval for Proposed US Redomiciliation

Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform huma...

July 09, 2026 | Thursday | News
TaiMed Biologics Secures TFDA Drug License Notice for Trogarzo Ahead of Taiwan Launch

TaiMed Biologics (TPEX: 4147) announced that its HIV therapy Trogarzo (ibalizumab; English name: Trogarzo Injection; Chinese name: 佐加洛注射劑) ha...

July 09, 2026 | Thursday | News
Danaher’s Abcam Partners with EpiCypher to Advance Epigenomics Research

Abcam, a Danaher company and a global provider of validated antibodies and assay solutions, and EpiCypher®, the leading provider of ChIC/CU...

July 09, 2026 | Thursday | News
Thermo Fisher’s Applied Biosystems RapidINTEL Plus Cartridge Receives FBI Approval for CODIS-Eligible Rapid DNA Crime Scene Profiles

Product: Applied Biosystems™ RapidINTEL™ Plus Cartridge used with the Applied Biosystems™ RapidHIT ID™ System Category: Rapid ...

July 09, 2026 | Thursday | News
Aligos Receives $25 Million Upfront Payment from Amoytop as Pevifoscorvir Sodium Secures Breakthrough Therapy Designation in China

Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapie...

July 08, 2026 | Wednesday | News
Genmab Secures European Approval for TEPKINLY Plus R2 as First Bispecific-Based Second-Line Follicular Lymphoma Therapy

TEPKINLY® (epcoritamab) plus lenalidomide and rituximab (R2) is the first and only bispecific-based therapy approved in Europe for the treatment of...

July 08, 2026 | Wednesday | News
FDA Expands Approval of Vertex’s CASGEVY to Children Aged Two and Older with Sickle Cell Disease and Beta Thalassemia

- First and only approved genetic therapy to treat children as young as 2 years for both severe sickle cell disease and transfusion-dependent beta thal...

July 03, 2026 | Friday | Regulatory
Thubrikar Aortic Valve Partners with MAC’s MEDICAL Group to Advance CE Mark Trial for Optimum TAVI System

  -Thubrikar Aortic Valve, Inc. announced its partnership with MAC’s MEDICAL Group, a distributor of cardiovascular devices in Europe, and MAC&...

June 30, 2026 | Tuesday | News
CHMP Recommends EU Approval of Incyte’s Opzelura for Moderate Atopic Dermatitis

If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults wit...

June 30, 2026 | Tuesday | News
Anivive Secures Full FDA Approval for AI-Developed Canine Lymphoma Therapy

Anivive converts Laverdia-CA1 to full FDA approval First FDA-approved product to validate Anivive's AI-enabled development model — from drug rep...

June 29, 2026 | Monday | News
CSL and VFMCRP Respond as CHMP Recommends Revoking TAVNEOS EU Authorization

Recommendation follows an Article 20 non-pharmacovigilance procedure  Patients currently on TAVNEOS treatment should consult their treating physi...

June 29, 2026 | Monday | News
Lilly's Jaypirca Moves Closer to EU Approval for All-Line CLL Treatment

The positive opinion is based on results from the Phase 3 BRUIN CLL-313 and BRUIN CLL-314 trials, previously presented at the 2025 American Society of He...

June 29, 2026 | Monday | News
Pfizer Expands IBRANCE Label with FDA Approval in HR+, HER2+ Metastatic Breast Cancer

First and only CDK4/6 inhibitor approved for HR+ metastatic disease regardless of HER2 status Approval based on data from the collaborative Phase 3 ...

June 26, 2026 | Friday | News
Pathway Labs Launches FDA-Cleared AI ECG Tool for Early Detection of Structural Heart Disease

Pathway Labs announced its public launch of EchoNext, the world’s first FDA-approved AI detection tool that reads standard 12-lead electrocard...

June 25, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close